Chile's health authorities have started vaccinating children aged between 6 and 12 against COVID-19 with the Chinese Coronavac drug to keep up the country's high immunization rate, which is among the most prolific worldwide.
Rio de Janeiro city officials have reported a local man was able to get vaccinated five times in ten weeks against covid-19, presumably thanks to failures in the electronic documenting system.
Chinese laboratory Sinovac Wednesday announced it will build a plant in Chile to locally distribute 60 million yearly doses of the Coronavac vaccine against COVID-19 with which to supply other Latin American countries.
A study by Chile's Catholic University has shown that the Chinese-developed Sinovac anticoronavirus vaccine's effectiveness was down after six months and patients would then need a third dose of the immunizer.
Uruguay's Public Health Ministry Tuesday reported that around 1,807,000 people, that is 51.15% of the country's population, have already been administered at least one dose of an anti-coronavirus vaccine.
The prestigious Butantan Institute Monday released the results of a study carried out between February and April 2021 among 27,000 people vaccinated with CoronaVac in Serrana, São Paulo, which showed a 95% decrease in deaths from covid-19, it was announced.
Butantan Institute Director Dimas Covas Thursday blamed President Jair Bolsonaro's anti-Chinese stance for the delay in the arrival and distribution of anti-covid-19 vaccines into Brazil.
Rio de Janeiro suspends Covid-19 vaccination campaign until next week because the Brazilian city has run out of doses, Mayor Eduardo Paes announced. I have been informed that the new doses did not arrive. We will have to interrupt our campaign from Tuesday, Paes wrote on Twitter.
The Director of the Butantan Institute on Tuesday contradicted the words of Uruguayan President Luis Lacalle Pou, assuring that there is not yet a closed agreement between the Uruguayan government and the Chinese laboratory Sinovac for the purchase of the vaccine against Covid-19. However, the institute affirmed that there is a pre-agreement and talks are still ongoing. Lacalle Pou announced on Saturday at a press conference the purchase of 1.75 million doses from this laboratory.
With the slow development of its own phase three clinical trial of a Covid-19 vaccine candidate, Indonesia said it has asked for data from Brazil, where a similar trial is progressing smoothly.